Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Personalized Plans No cookie-cutter diets or random prescriptionsyour plan is tailored to your goals, labs, and medical history
Lynparza (olaparib) Disease area(s): Oncology Manufacturer(s): AstraZeneca/Merck 2024 Sales (USD): $4.98 billion Why it sold so well: AstraZenecas Lynparza delivered a strong sales performance in 2024, with product revenues reaching $3.67 billion, marking a 22% increase at constant exchange rates compared to the previous year
Dec 17 (Reuters) - Eli Lilly is slashing the prices of its popular diabetes and weight-loss drugs Mounjaro and Zepbound by 20% or more in Canada, the Globe and Mail reported on Wednesday, citing a note to pharmacies issued by the U.S.-based drugmaker
Cons EllaOla is relatively expensive compared to other supplement brands
It depends on the plan
doi:10.1038/s41366-025-01859-6
US$ 24.71
US$ 22.90
US$ 20.67
